Metolazone 5 MG Oral Tablet — RxCUI 311671
RxNorm drug concept · Semantic clinical drug
RxCUI 311671
Semantic clinical drug · SCD
● Current RxNorm concept 60 FDA products
86 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI311671
Official nameMetolazone 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped60
Package NDCs mapped86
Reported Medicaid activity (SDUD)56,621 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Metolazone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Think of your kidneys as a filter. Normally, they reabsorb a lot of the sodium (salt) that passes through them. Metolazone blocks that process, so more sodium — and the water that...
- What is metolazone actually doing in my body?
- Because metolazone makes your kidneys flush out more than just water — it also causes you to lose potassium, sodium, and magnesium. If those levels drop too low, you can develop mu...
- Why does my doctor keep checking my blood levels while I'm on this?
🕸️ Concept Web — How Metolazone 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Metolazone 5 MG Oral Tablet
RxCUI 311671 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Metolazone
6916IN
-
Metolazone
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Metolazone Oral Tablet
372888SCDF -
Metolazone Oral Product
1163518SCDG -
Metolazone Pill
1163519SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Metolazone Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Metolazone 5 MG
316299SCDC
-
Metolazone 5 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Metolazone 5 MG
SCDC · 316299 -
Metolazone Oral Tablet
SCDF · 372888 -
Metolazone Oral Product
SCDG · 1163518 -
Metolazone Pill
SCDG · 1163519
📦 FDA Products & Package NDCs
60 products · 86 package NDCs
86 package NDCs map to RxCUI 311671 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00185-0055-01 | 100 TABLET in 1 BOTTLE (0185-0055-01) | Metolazone | Sandoz Inc | 2003-12-19 |
| 00185-0055-10 | 1000 TABLET in 1 BOTTLE (0185-0055-10) | Metolazone | Sandoz Inc | 2003-12-19 |
| 00185-5050-01 | 100 TABLET in 1 BOTTLE (0185-5050-01) | Metolazone | Sandoz Inc | 2003-12-19 |
| 00185-5050-10 | 1000 TABLET in 1 BOTTLE (0185-5050-10) | Metolazone | Sandoz Inc | 2003-12-19 |
| 00185-5600-01 | 100 TABLET in 1 BOTTLE (0185-5600-01) | Metolazone | Sandoz Inc | 2003-12-19 |
| 00185-5600-10 | 1000 TABLET in 1 BOTTLE (0185-5600-10) | Metolazone | Sandoz Inc | 2003-12-19 |
| 00378-6172-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-6172-01) | Metolazone | Mylan Pharmaceuticals Inc. | 2004-01-06 |
| 00378-6173-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-6173-01) | Metolazone | Mylan Pharmaceuticals Inc. | 2004-10-19 |
| 00378-6174-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-6174-01) | Metolazone | Mylan Pharmaceuticals Inc. | 2004-11-19 |
| 00904-7329-61 | 100 BLISTER PACK in 1 CARTON (0904-7329-61) / 1 TABLET in 1... | Metolazone | Major Pharmaceuticals | 2023-08-30 |
| 00904-7520-61 | 100 BLISTER PACK in 1 CARTON (0904-7520-61) / 1 TABLET in 1... | Metolazone | Major Pharmaceuticals | 2025-11-20 |
| 00904-7521-61 | 100 BLISTER PACK in 1 CARTON (0904-7521-61) / 1 TABLET in 1... | Metolazone | Major Pharmaceuticals | 2025-11-20 |
| 10135-0765-01 | 100 TABLET in 1 BOTTLE (10135-765-01) | METOLAZONE | Marlex Pharmaceuticals, Inc. | 2022-12-01 |
| 10135-0765-10 | 1000 TABLET in 1 BOTTLE (10135-765-10) | METOLAZONE | Marlex Pharmaceuticals, Inc. | 2022-12-01 |
| 10135-0766-01 | 100 TABLET in 1 BOTTLE (10135-766-01) | METOLAZONE | Marlex Pharmaceuticals, Inc. | 2022-12-01 |
| 10135-0766-10 | 1000 TABLET in 1 BOTTLE (10135-766-10) | METOLAZONE | Marlex Pharmaceuticals, Inc. | 2022-12-01 |
| 10135-0767-01 | 100 TABLET in 1 BOTTLE (10135-767-01) | METOLAZONE | Marlex Pharmaceuticals, Inc. | 2022-12-01 |
| 10135-0767-10 | 1000 TABLET in 1 BOTTLE (10135-767-10) | METOLAZONE | Marlex Pharmaceuticals, Inc. | 2022-12-01 |
| 42571-0416-01 | 100 TABLET in 1 CONTAINER (42571-416-01) | Metolazone | Micro Labs Limited | 2025-03-01 |
| 42571-0416-10 | 1000 TABLET in 1 CONTAINER (42571-416-10) | Metolazone | Micro Labs Limited | 2025-03-01 |
| 42571-0417-01 | 100 TABLET in 1 CONTAINER (42571-417-01) | Metolazone | Micro Labs Limited | 2025-03-01 |
| 42571-0417-10 | 1000 TABLET in 1 CONTAINER (42571-417-10) | Metolazone | Micro Labs Limited | 2025-03-01 |
| 42571-0418-01 | 100 TABLET in 1 CONTAINER (42571-418-01) | Metolazone | Micro Labs Limited | 2025-03-01 |
| 42571-0418-10 | 1000 TABLET in 1 CONTAINER (42571-418-10) | Metolazone | Micro Labs Limited | 2025-03-01 |
| 43353-0890-09 | 9000 TABLET in 1 BOTTLE, PLASTIC (43353-890-09) | Metolazone | Aphena Pharma Solutions - Tennessee, LLC | 2014-02-26 |
| 43353-0931-09 | 9000 TABLET in 1 BOTTLE, PLASTIC (43353-931-09) | Metolazone | Aphena Pharma Solutions - Tennessee, LLC | 2014-04-24 |
| 46708-0532-31 | 100 TABLET in 1 BOTTLE (46708-532-31) | METOLAZONE | Alembic Pharmaceuticals Limited | 2020-12-02 |
| 46708-0532-91 | 1000 TABLET in 1 BOTTLE (46708-532-91) | METOLAZONE | Alembic Pharmaceuticals Limited | 2020-12-02 |
| 46708-0533-31 | 100 TABLET in 1 BOTTLE (46708-533-31) | METOLAZONE | Alembic Pharmaceuticals Limited | 2020-12-02 |
| 46708-0533-91 | 1000 TABLET in 1 BOTTLE (46708-533-91) | METOLAZONE | Alembic Pharmaceuticals Limited | 2020-12-02 |
| 46708-0534-31 | 100 TABLET in 1 BOTTLE (46708-534-31) | METOLAZONE | Alembic Pharmaceuticals Limited | 2020-12-02 |
| 46708-0534-91 | 1000 TABLET in 1 BOTTLE (46708-534-91) | METOLAZONE | Alembic Pharmaceuticals Limited | 2020-12-02 |
| 48433-0068-20 | 100 BLISTER PACK in 1 CARTON (48433-068-20) / 1 TABLET in 1... | Metolazone | Safecor Health LLC | 2026-02-19 |
| 48433-0069-20 | 100 BLISTER PACK in 1 CARTON (48433-069-20) / 1 TABLET in 1... | Metolazone | Safecor Health LLC | 2026-02-19 |
| 50742-0349-01 | 100 TABLET in 1 BOTTLE (50742-349-01) | Metolazone | Ingenus Pharmaceuticals LLC | 2023-01-24 |
| 50742-0350-01 | 100 TABLET in 1 BOTTLE (50742-350-01) | Metolazone | Ingenus Pharmaceuticals LLC | 2023-01-24 |
| 50742-0351-01 | 100 TABLET in 1 BOTTLE (50742-351-01) | Metolazone | Ingenus Pharmaceuticals LLC | 2023-01-24 |
| 51079-0023-20 | 100 BLISTER PACK in 1 CARTON (51079-023-20) / 1 TABLET in 1... | Metolazone | Mylan Institutional Inc. | 2005-04-15 |
| 51079-0024-20 | 100 BLISTER PACK in 1 CARTON (51079-024-20) / 1 TABLET in 1... | Metolazone | Mylan Institutional Inc. | 2005-02-01 |
| 51407-0431-01 | 100 TABLET in 1 BOTTLE (51407-431-01) | Metolazone | Golden State Medical Supply, Inc. | 2021-06-29 |
| 51407-0432-01 | 100 TABLET in 1 BOTTLE (51407-432-01) | Metolazone | Golden State Medical Supply, Inc. | 2021-06-29 |
| 51407-0433-01 | 100 TABLET in 1 BOTTLE (51407-433-01) | Metolazone | Golden State Medical Supply, Inc. | 2021-06-29 |
| 58657-0740-01 | 100 TABLET in 1 BOTTLE (58657-740-01) | Metolazone | Method Pharmaceuticals, LLC | 2024-06-15 |
| 58657-0740-10 | 1000 TABLET in 1 BOTTLE (58657-740-10) | Metolazone | Method Pharmaceuticals, LLC | 2024-06-15 |
| 58657-0741-01 | 100 TABLET in 1 BOTTLE (58657-741-01) | Metolazone | Method Pharmaceuticals, LLC | 2024-06-15 |
| 58657-0741-10 | 1000 TABLET in 1 BOTTLE (58657-741-10) | Metolazone | Method Pharmaceuticals, LLC | 2024-06-15 |
| 58657-0742-01 | 100 TABLET in 1 BOTTLE (58657-742-01) | Metolazone | Method Pharmaceuticals, LLC | 2024-06-15 |
| 58657-0742-10 | 1000 TABLET in 1 BOTTLE (58657-742-10) | Metolazone | Method Pharmaceuticals, LLC | 2024-06-15 |
| 58657-0940-01 | 100 BLISTER PACK in 1 CARTON (58657-940-01) / 1 TABLET in 1... | Metolazone | Method Pharmaceuticals, LLC | 2026-01-28 |
| 58657-0941-01 | 100 BLISTER PACK in 1 CARTON (58657-941-01) / 1 TABLET in 1... | Metolazone | Method Pharmaceuticals, LLC | 2026-01-28 |
Observed labelers:
Method Pharmaceuticals, LLC (9) ·
Bryant Ranch Prepack (8) ·
Aarkish Pharmaceuticals NJ Inc. (6) ·
Alembic Pharmaceuticals Inc. (6) ·
Alembic Pharmaceuticals Limited (6) ·
Amici Pharma, Inc (6)
· +13 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.